Health Canada Approves Johnson & Johnson COVID-19 Vaccine – Quick Facts

Chindata Group Q3 Adj. Net Income Rises; Revenues Up 58.5%

Chindata Group Holdings Limited (CD) reported third quarter net income of RMB 78.4 million compared to a net loss of RMB 196.8 million, last year. Profit per ADS was RMB 0.22. Adjusted net income increased by 132.2% to RMB 112.0 million. Adjusted EBITDA increased by 61.6% to RMB 368.4 million.

Total revenues increased by 58.5% to RMB 740.8 million from RMB 467.5 million, prior year, primarily driven by the growth of colocation services.

The company reiterated its guidance for full year 2021.

Pre-market Movers: OCUP, KTTA, GAME, BIOL, JWN…

The following are some of the stocks making big moves in Wednesday’s pre-market trading (as of 07.05 A.M. ET).

In the Green

Ocuphire Pharma, Inc. (OCUP) is up over 50% at $5.23
Pasithea Therapeutics Corp. (KTTA) is up over 40% at $7.86
Engine Gaming and Media, Inc. (GAME) is up over 33% at $4.26
BIOLASE, Inc. (BIOL) is up over 29% at $0.55
Society Pass Incorporated (SOPA) is up over 27% at $14.27
Pure Storage, Inc. (PSTG) is up over 14% at $31.14
Synlogic, Inc. (SYBX) is up over 14% at $2.75
Longeveron Inc. (LGVN) is up over 11% at $19.23

In the Red

Nordstrom, Inc. (JWN) is down over 27% at $23.22
Vallon Pharmaceuticals, Inc. (VLON) is down over 27% at $5.30
The Gap, Inc. (GPS) is down over 20% at $18.70
iSpecimen Inc. (ISPC) is down over 20% at $10.52
Petros Pharmaceuticals, Inc. (PTPI) is down over 20% at $1.87
Outlook Therapeutics, Inc. (OTLK) is down over 20% at $1.24
Qualigen Therapeutics, Inc. (QLGN) is down over 17% at $2.12
Aptevo Therapeutics Inc. (APVO) is down over 15% at $14.45
Esperion Therapeutics, Inc. (ESPR) is down over 15% at $8.50
Clarus Therapeutics Holdings, Inc. (CRXT) is down over 13% at $4.94
MediciNova, Inc. (MNOV) is down over 13% at $3.82

General Mills To Sell European Dough Businesses To Cérélia – Quick Facts

General Mills (GIS) announced Wednesday that it has agreed to sell its European dough businesses to Cérélia, a global leader in ready-to-bake dough solutions. Financial terms of the deal were not disclosed.

The proposed transactions would include General Mills branded and private label dough businesses in Germany, the UK, and Ireland, including the Knack & Back and Jus-Rol brands.

Each of the transactions is expected to close by the end of fiscal 2022, with the German transaction subject to appropriate labor consultations, regulatory approvals, and other customary closing conditions.

These divestitures represent another step in the General Mills Accelerate strategy, which is centered on clear priorities on where to play – across geographies as well as platforms and brands – to drive long-term, superior shareholder returns.

As part of the strategy, the company intends ti increase its focus on advantaged global platforms, which include Mexican food, super-premium ice cream and snack bars.

Russia's Putin took part in trials of nasal form of COVID vaccine

Russian President Vladimir Putin attends a meeting with government members via a video link in Sochi, Russia November 24, 2021. Sputnik/Mikhail Metzel/Pool via REUTERS

MOSCOW (Reuters) – Russian President Vladimir Putin said on Wednesday he had participated in trials of a nasal form of a vaccine against COVID-19.

Putin was revaccinated against the coronavirus on Sunday with Russia’s Sputnik Light shot.

European Economics Preview: German Ifo Business Confidence Data Due

Business sentiment survey results from Germany and France are due on Wednesday, headlining a light day for the European economic news.

At 2.45 am ET, France’s statistical office Insee publishes business sentiment survey results. The business confidence index is expected to drop to 106 in November from 107 in October.

At 3.00 am ET, business sentiment data is due from the Czech Republic.

At 4.00 am ET, Germany’s ifo Institute is scheduled to issue business sentiment data. The confidence index is seen at 96.6 in November versus 97.7 in October.

At 6.00 am ET, the Confederation of British Industry releases Industrial Trends survey results. The order book balance is expected to improve to 13 in November from 9 in the previous month.

Biofrontera Continues Rally

Biofrontera Inc. (BFRI) shares are surging more than 133 percent on Wednesday morning trade, continuing an uptrend since yesterday. The dermatological products company said it has scheduled its third-quarter results on November 30.

Currently, shares are at $6.21, up 135.99 percent from the previous close of $2.63 on a volume of 76,725,418. For the 52-week period, the shares have traded in a range of $2.25-$6.38 on average volume of 1,734,583.

Health Canada Approves Johnson & Johnson COVID-19 Vaccine – Quick Facts

Janssen, the pharmaceutical companies of Johnson & Johnson (JNJ), announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.

“We are delighted by Health Canada’s decision to approve the Johnson & Johnson COVID-19 vaccine based on phase 3 clinical data that proves the vaccine’s robust safety and efficacy,” said Mathai Mammen, Global Head, Janssen Research & Development, Johnson & Johnson.

Initial data from the phase 3 ENSEMBLE study showed the vaccine was 85 percent effective in preventing severe disease, and demonstrated protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination. The study enrolled a total of 43,783 participants.

The Janssen COVID-19 single-dose vaccine is compatible with standard vaccine storage and distribution channels. It leverages the AdVac vaccine platform, a proprietary technology.